Oxygenta Pharmaceutical Limited (BOM:524636)

Oxygenta Pharmaceutical Statistics

Total Valuation

BOM:524636 has a market cap or net worth of INR 2.20 billion. The enterprise value is 2.91 billion.

Market Cap	2.20B
Enterprise Value	2.91B

Important Dates

The next estimated earnings date is Saturday, February 14, 2026.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:524636 has 36.98 million shares outstanding. The number of shares has increased by 7.59% in one year.

Current Share Class	36.98M
Shares Outstanding	36.98M
Shares Change (YoY)	+7.59%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	33.41%
Owned by Institutions (%)	n/a
Float	3.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.96
PB Ratio	-5.99
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	47.83
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.64
EV / Sales	2.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.96

Financial Position

The company has a current ratio of 0.42

Current Ratio	0.42
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-6.49
Interest Coverage	-7.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-11.97%
Return on Invested Capital (ROIC)	-50.98%
Return on Capital Employed (ROCE)	220.21%
Weighted Average Cost of Capital (WACC)	5.96%
Revenue Per Employee	6.41M
Profits Per Employee	-943,097
Employee Count	175
Asset Turnover	1.18
Inventory Turnover	5.67

Taxes

Income Tax	-40.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.35% in the last 52 weeks. The beta is 0.51, so BOM:524636's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-28.35%
50-Day Moving Average	57.58
200-Day Moving Average	80.16
Relative Strength Index (RSI)	57.67
Average Volume (20 Days)	2,831

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524636 had revenue of INR 1.12 billion and -165.04 million in losses. Loss per share was -4.47.

Revenue	1.12B
Gross Profit	-47.04M
Operating Income	-181.94M
Pretax Income	-205.51M
Net Income	-165.04M
EBITDA	-169.83M
EBIT	-181.94M
Loss Per Share	-4.47

Balance Sheet

The company has 12.40 million in cash and 728.29 million in debt, with a net cash position of -715.89 million or -19.36 per share.

Cash & Cash Equivalents	12.40M
Total Debt	728.29M
Net Cash	-715.89M
Net Cash Per Share	-19.36
Equity (Book Value)	-366.79M
Book Value Per Share	-9.89
Working Capital	-731.09M

Cash Flow

In the last 12 months, operating cash flow was 45.90 million and capital expenditures -158.03 million, giving a free cash flow of -112.13 million.

Operating Cash Flow	45.90M
Capital Expenditures	-158.03M
Free Cash Flow	-112.13M
FCF Per Share	-3.03

Margins

Gross margin is -4.20%, with operating and profit margins of -16.23% and -14.72%.

Gross Margin	-4.20%
Operating Margin	-16.23%
Pretax Margin	-18.33%
Profit Margin	-14.72%
EBITDA Margin	-15.15%
EBIT Margin	-16.23%
FCF Margin	n/a

Dividends & Yields

BOM:524636 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.59%
Shareholder Yield	-7.59%
Earnings Yield	-7.52%
FCF Yield	-5.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4